格隆汇9月29日|上海凯赛生物技术股份有限公司公告,为满足非全资控股子公司发展和经营需求,授权其在其他非全资控股子公司申请信贷及日常经营时提供担保,授权期内担保发生余额合计不超20亿元,实际金额以合同或批复为准。截至公告日,非全资控股子公司对外担保总额5亿元,均为子公司间担保,无逾期及涉诉担保。主要被担保人包括凯赛(太原)生物材料有限公司、凯赛(太原)生物科技有限公司,二者资产负债率未超70%。...
Source Link格隆汇9月29日|上海凯赛生物技术股份有限公司公告,为满足非全资控股子公司发展和经营需求,授权其在其他非全资控股子公司申请信贷及日常经营时提供担保,授权期内担保发生余额合计不超20亿元,实际金额以合同或批复为准。截至公告日,非全资控股子公司对外担保总额5亿元,均为子公司间担保,无逾期及涉诉担保。主要被担保人包括凯赛(太原)生物材料有限公司、凯赛(太原)生物科技有限公司,二者资产负债率未超70%。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.